L
Lineage Cell Therapeutics, Inc.LCTX
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel allogeneic, or'off the shelf', cell therapies for serious medical conditions. Lineage's programs are based on its proprietary cell-based technology platform, AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and associated development and manufacturing capabilities. From this proprietary AlloSCOPE platform, Lineage develops, manufactures, and tests specialized human cells with anatomical and physiological functions similar or substantially identical to cells found naturally in the human.
US StocksBiotechnologyHealthcareSmall Cap
LCTX Price Trend
Lineage Cell Therapeutics, Inc. · Full TradingView Chart
NASDAQ:LCTX